Atlas Trials

Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy

Clinical trial NCT02984813 · TERMINATED

Trial details

NCT number
NCT02984813
Sponsor
The New York Eye & Ear Infirmary
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Open-angle GlaucomaDiabetic Retinopathy
Start date
2016-04-15
Primary completion
2017-01-15
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.